Carta científico-clínica
Eficacia y seguridad de omalizumab en un paciente con urticaria crónica espontánea e infección activa por el virus de la hepatitis B
Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection
P. Chicharro
, P. Rodríguez-Jiménez, D. de Argila
Autor para correspondencia
Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España
Leído
7389
Vecesse ha leído el artículo
2289
Total PDF
5100
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 98 | 7 | 105 |
| 2025 5 | 153 | 42 | 195 |
| 2025 4 | 170 | 34 | 204 |
| 2025 3 | 189 | 21 | 210 |
| 2025 2 | 145 | 36 | 181 |
| 2025 1 | 110 | 27 | 137 |
| 2024 12 | 91 | 36 | 127 |
| 2024 11 | 95 | 65 | 160 |
| 2024 10 | 70 | 36 | 106 |
| 2024 9 | 78 | 21 | 99 |
| 2024 8 | 97 | 58 | 155 |
| 2024 7 | 72 | 30 | 102 |
| 2024 6 | 111 | 31 | 142 |
| 2024 5 | 78 | 29 | 107 |
| 2024 4 | 101 | 32 | 133 |
| 2024 3 | 80 | 35 | 115 |
| 2024 2 | 65 | 32 | 97 |
| 2024 1 | 73 | 22 | 95 |
| 2023 12 | 71 | 32 | 103 |
| 2023 11 | 86 | 42 | 128 |
| 2023 10 | 64 | 28 | 92 |
| 2023 9 | 73 | 25 | 98 |
| 2023 8 | 86 | 21 | 107 |
| 2023 7 | 93 | 32 | 125 |
| 2023 6 | 51 | 25 | 76 |
| 2023 5 | 74 | 23 | 97 |
| 2023 4 | 59 | 25 | 84 |
| 2023 3 | 90 | 22 | 112 |
| 2023 2 | 79 | 38 | 117 |
| 2022 1 | 72 | 20 | 92 |
| 2022 12 | 81 | 36 | 117 |
| 2022 11 | 77 | 44 | 121 |
| 2022 10 | 83 | 45 | 128 |
| 2022 9 | 59 | 43 | 102 |
| 2022 8 | 78 | 60 | 138 |
| 2022 7 | 57 | 48 | 105 |
| 2022 6 | 61 | 27 | 88 |
| 2022 5 | 71 | 42 | 113 |
| 2022 4 | 65 | 27 | 92 |
| 2022 3 | 83 | 55 | 138 |
| 2022 2 | 82 | 35 | 117 |
| 2021 1 | 101 | 41 | 142 |
| 2021 12 | 76 | 43 | 119 |
| 2021 11 | 62 | 43 | 105 |
| 2021 10 | 56 | 70 | 126 |
| 2021 9 | 50 | 33 | 83 |
| 2021 8 | 101 | 36 | 137 |
| 2021 7 | 75 | 37 | 112 |
| 2021 6 | 51 | 41 | 92 |
| 2021 5 | 52 | 57 | 109 |
| 2021 4 | 105 | 88 | 193 |
| 2021 3 | 92 | 37 | 129 |
| 2021 2 | 53 | 32 | 85 |
| 2020 1 | 56 | 32 | 88 |
| 2020 12 | 41 | 28 | 69 |
| 2020 11 | 38 | 25 | 63 |
| 2020 10 | 44 | 30 | 74 |
| 2020 9 | 65 | 30 | 95 |
| 2020 8 | 62 | 22 | 84 |
| 2020 7 | 38 | 16 | 54 |
| 2020 6 | 44 | 41 | 85 |
| 2020 5 | 45 | 21 | 66 |
| 2020 4 | 29 | 33 | 62 |
| 2020 3 | 37 | 21 | 58 |
| 2020 2 | 0 | 1 | 1 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 1 | 0 | 1 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 5 | 6 | 11 |
| 2019 4 | 2 | 3 | 5 |
| 2019 3 | 1 | 0 | 1 |
| 2019 2 | 4 | 0 | 4 |
| 2019 1 | 4 | 0 | 4 |
| 2018 12 | 4 | 0 | 4 |
| 2018 11 | 2 | 2 | 4 |
| 2018 10 | 9 | 2 | 11 |
| 2018 9 | 8 | 0 | 8 |
| 2018 8 | 1 | 0 | 1 |
| 2018 7 | 1 | 0 | 1 |
| 2018 6 | 1 | 0 | 1 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 5 | 1 | 6 |
| 2018 1 | 7 | 0 | 7 |
| 2017 12 | 7 | 1 | 8 |
| 2017 11 | 9 | 0 | 9 |
| 2017 10 | 6 | 0 | 6 |
| 2017 9 | 10 | 2 | 12 |
| 2017 8 | 8 | 3 | 11 |
| 2017 7 | 3 | 3 | 6 |
| 2017 6 | 14 | 2 | 16 |
| 2017 5 | 18 | 8 | 26 |
| 2017 4 | 1 | 1 | 2 |
| 2017 2 | 0 | 3 | 3 |
| 2016 1 | 0 | 2 | 2 |
| 2016 12 | 0 | 3 | 3 |
Mostrar todo
